Special edition – Article 2

Perceptions of generic medicines and the cost-benefits of generic switches

This is the second article in the mini-series on generic medicines. Here, we focus on the perceptions of patients and healthcare professionals on generic products, with some valuable insight provided by Gail Chan, Team Leader for a Practice-based Commissioning (PBC) Group in Liverpool and Medicines Management Team Leader for Diabetes. A brief outline of the main events surrounding loss of patent protection and important cost considerations for commissioners of pharmaceuticals will also be given.

Download the PDF of Article 2 here